Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/2012
05/09/2012CN101935407B Preparation method of superfine bacteria cellulose powder
05/09/2012CN101927000B Medicine composite of superfine sterile sodium carbonate and cephems
05/09/2012CN101836960B Cefamandole nafate/anhydrous sodium carbonate medicinal composition microsphere injection
05/09/2012CN101810584B Microsphere injection of medicinal composition of cefotiam hydrochloride and anhydrous sodium carbonate
05/09/2012CN101804021B Preparation method of polyene-containing taxol nanoparticle mixed micelle preparation and freeze-drying agent
05/09/2012CN101797229B Immune liposome based on Isthmin gene as well as preparation method and application thereof
05/09/2012CN101780116B Chinese medical extractum dropping pill with food grade matrix and preparation method thereof
05/09/2012CN101724162B Preparation method of nano micellar solution of polymer with simulated cellulosa membrane structure
05/09/2012CN101703470B Solid preparation of fluconazole liposome and new application thereof
05/09/2012CN101653611B Albumin-adriamycin nano preparation, preparing method and application thereof
05/09/2012CN101623498B Dual-target tumor vaccine based on tumor endothelium marker-8 gene and preparation method thereof
05/09/2012CN101591818B Shikonin PCL/PTMC composite nanometer fiber and preparation and application thereof
05/09/2012CN101590033B Medicinal composition fat emulsion injection containing eucalyptol, limonene and alpha-pinene and preparation method
05/09/2012CN101530466B Nano medicament containing oregano oil and vitamins
05/09/2012CN101514229B Human interferon alpha derivative and polyethylene glycol modified substance thereof
05/09/2012CN101380309B Metered dose inhalation aerosol and preparation method thereof
05/09/2012CN101293037B Segmented intestine targeting medicine delivery preparation of Chinese medicine and preparation method thereof
05/09/2012CN101209238B Biological degradation type long-acting hypodermal contraception implant containing gestodene and preparation thereof
05/09/2012CN101190231B Bykomycin chewable tablets for dog or cat
05/09/2012CN101116657B Externally- used contraception emulsion and method for preparing the same
05/09/2012CN101048164B Compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
05/09/2012CN101014620B Antibodies against clostridium difficile toxins and uses thereof
05/08/2012US8173709 Anti-infective methods for treating pathogen-induced disordered tissues
05/08/2012US8173694 Therapeutic agent
05/08/2012US8173594 Stabilizing alkylglycoside compositions and methods thereof
05/08/2012US8173424 Internalizing ErbB2 antibodies
05/08/2012US8173411 Drying process for preserving an active agent as a highly viscous liquid
05/08/2012US8173176 Embolization
05/08/2012US8173172 Preparation of powder agglomerates
05/08/2012US8173156 Method for avoiding crystallization of anti-inflammatory agent in plaster formulation
05/08/2012US8173150 Stable non-aqueous single phase viscous vehicles and formulations utlizing such vehicles
05/08/2012US8173149 Method for producing porous β-tricalcium phosphate granules
05/08/2012US8173145 Formulation containing phosphate derivatives of electron transfer agents
05/08/2012US8173142 Pharmaceutical compositions of drugs and neutralized acidic polymers
05/08/2012US8173141 Immunogenic complexes and methods relating thereto
05/08/2012US8173138 Stable liquid formulations of botulinum toxin
05/08/2012US8173133 Acyl pseudodipeptides which carry a functionalized auxiliary arm
05/08/2012US8173115 Particle compositions with a pre-selected cell internalization mode
05/08/2012US8173107 Delivery of antipsychotics through an inhalation route
05/08/2012CA2550370C Stabilized formulation of ivermectin feed premix with an extended shelf life and method of making the same
05/08/2012CA2541005C Fibrinogen targetting microparticles for promoting haemostasis
05/08/2012CA2532565C Use of calcitonin in osteoarthritis
05/08/2012CA2531847C Hfc solution formulations containing an anticholinergic
05/08/2012CA2529604C Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form
05/08/2012CA2519195C Adhesive patch containing non-steroidal anti-inflammatory agent
05/08/2012CA2491164C Method and apparatus for producing liposomes
05/08/2012CA2478655C Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
05/08/2012CA2458386C L-methionine as a stabilizer for nesp/epo in hsa-free formulations
05/08/2012CA2430824C Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient
05/08/2012CA2383724C Drug delivery system using membrane mimetics
05/03/2012WO2012058573A1 Use of phosphodiesterase inhibitor to enhance post-surgical erection in men undergoing radical prostatectomy
05/03/2012WO2012058545A2 Process for analyzing and establishing dosage size in an ingestible film
05/03/2012WO2012058392A1 Solid dispersions containing an apoptosis-inducing agent
05/03/2012WO2012058378A1 Pharmaceutical compositions and methods of use of salicylanilides for treatment of hepatitis viruses
05/03/2012WO2012057895A2 Composition and method for treating wounds
05/03/2012WO2012057628A2 Cross-linked polymers and implants derived from electrophilically activated polyoxazoline
05/03/2012WO2012057525A2 Liquid formulations of long acting interferon alpha conjugate
05/03/2012WO2012057492A2 Rapamycin formulation using recombinant high-density lipoprotein including apolipoprotein a-i and a mutant thereof
05/03/2012WO2012057375A1 Method for preparing cosmetic composition comprising nanoparticles containing acer mono sap treated with high hydrostatic pressure and cosmetic composition prepared thereby
05/03/2012WO2012057374A1 Multi-functional cosmetic composition and preparation method thereof
05/03/2012WO2012057312A1 Tau imaging probe
05/03/2012WO2012057220A1 Percutaneously absorbed preparation
05/03/2012WO2012057212A1 Percutaneous absorption type formulation
05/03/2012WO2012057103A1 Pharmaceutical composition
05/03/2012WO2012056956A1 Vesicle composition, and external skin preparation and cosmetic, each containing same
05/03/2012WO2012056476A1 A detoxifier herbal formulation
05/03/2012WO2012056387A2 A dermaceutical gel made using sodium fusidate and a process to make it
05/03/2012WO2012056299A1 Nasal compositions of vitamin b12
05/03/2012WO2012055944A1 Oral pharmaceutical film formulation for bitter-tasting drugs
05/03/2012WO2012055933A1 Liposome-based construct comprising a peptide modified through hydrophobic moieties
05/03/2012WO2012055854A1 Spider silk fusion protein structures for binding to an organic target
05/03/2012WO2012055568A1 Liposomal drug composition containing a polymeric guanidine derivative
05/03/2012WO2012055205A1 Pegylated recombinant consensus interferon variant conjugate and preparation mehtod and uses thereof
05/03/2012WO2012055030A1 Clostridium difficile-specific antibodies and uses thereof
05/03/2012WO2012055020A1 Thermosensitive liposomes
05/03/2012WO2012019024A3 Her3-binding molecules and immunoconjugates thereof
05/03/2012WO2012003476A3 Hapten conjugates for target detection
05/03/2012WO2012002760A3 Method for treating and diagnosing cancer by using cell-derived microvesicles
05/03/2012WO2012002759A3 Microvesicles derived from cell protoplast, and use thereof
05/03/2012WO2012002715A3 Temperature-sensitive bioactive material carrier and method for preparing same
05/03/2012WO2011159161A3 Boronated polymers
05/03/2012WO2011151079A3 Preparation for use in ophthalmology and retinal surgery
05/03/2012WO2011139254A3 Pharmaceutical formulations compising cefuroxime axetil
05/03/2012WO2011130753A3 Functionalized nano- and micro-materials for medical therapies
05/03/2012WO2011128634A3 Over the counter pharmaceutical compositions
05/03/2012WO2011126839A3 Compositions and methods for improved retention of a pharmaceutical composition at a local administration site
05/03/2012WO2011120903A3 A fast dissolving pharmaceutical composition
05/03/2012WO2011119995A3 Formulations and methods of use
05/03/2012WO2011085957A3 Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogs
05/03/2012WO2011082796A3 Temperature-dependent activation of catalytic nucleic acids for controlled active substance release
05/03/2012US20120108680 Long-chain glycyl polyol type gelator and gel
05/03/2012US20120108679 Branched copolymers, composition and uses
05/03/2012US20120108678 Branched copolymers, compositions and uses
05/03/2012US20120108677 Iminic monomers and polymers thereof
05/03/2012US20120108676 Aerosol-mediated particle synthesis
05/03/2012US20120108664 Transdermal delivery of beneficial substances effected by a hostile biophysical environment
05/03/2012US20120108621 Pharmaceutical preparation containing oxycodone and naloxone
05/03/2012US20120108560 Single phase silicone acrylate formulation
05/03/2012US20120108520 Antimicrobial Compounds and Formulations
05/03/2012US20120108511 Preparation of biodegradable polyesters with low-burst properties by supercritical fluid extraction
1 ... 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 ... 1712